|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/21 | |
| A61P 35/00 |
| (11) | Number of the document | 2621516 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11829825.6 |
| Date of filing the European patent application | 2011-09-28 | |
| (97) | Date of publication of the European application | 2013-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/053681 |
| Date | 2011-09-28 |
| (87) | Number | WO 2012/044684 |
| Date | 2012-04-05 |
| (30) | Number | Date | Country code |
| 389009 P | 2010-10-01 | US |
| (72) |
BAKER, Darren, P., US
JOSEPH, Ingrid, B.J.K., US
WANG, Xinzhong, US
|
| (73) |
Biogen MA Inc.,
250 Binney Street, Cambridge, MA 02142,
US
|
| (54) | INTERFERON-BETA FOR USE AS MONOTHERAPY OR IN COMBINATION WITH OTHER CANCER THERAPIES |
| INTERFERON-BETA FOR USE AS MONOTHERAPY OR IN COMBINATION WITH OTHER CANCER THERAPIES |